Official EU label nameGlossary entry 25085
SALICYLIC ACID
This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.
Global evidence snapshot
The resolved identity has matching regulatory evidence in 9 of 13 indexed market datasets: 12 country records and 1 EU Annex records. Every result and evidence gap is listed below.
Markets checked
13
Markets with evidence
9
Evidence gaps
4
Resolved identifiers
9
A missing local match is not permission, approval or proof of safety. It means no strong identity match was resolved in that indexed dataset.
Resolved substance identity
CAS:69-72-7824-35-118917-89-059866-70-554-21-7578-36-92174-16-517671-53-3
EC:200-712-3
Ingredient index records:
SALICYLIC ACID
Ph. Eur. name: acidum salicylicum
Cosmetic functions: ANTI-SEBORRHEIC, FRAGRANCE, HAIR CONDITIONING, KERATOLYTIC, PRESERVATIVE, SKIN CONDITIONING
Salicylic acid
Inventory restriction note: III/98 V/3
12 matched or reported names
SALICYLIC ACIDsalicylic acidacidum salicylicumBenzoic acid, 2-hydroxy-Salicylic acidSalicylic acid and its saltsSalicylic acid (benzoic acid, 2-hydroxy-)Salicylic acid (69-72-7) and its salts(1) : Calcium salicylate (CAS No. 824-35- 1), Magnesium salicylate (CAS No. 18917-89- 0), MEA-salicylate (CAS No. 59866-70-5), Sodium salicylate (CAS No. 54-21-7), Potassium salicylate (CAS No. 578-36-9), TEA- salicylate (CAS No. 2174-16-5)Benzoic acid, 2-hydroxy- Salicylic acid CAS No 69-72-7살리실릭애씨드 및그 염류살리실릭애씨드 및 그염류Benzoic acid, 2-hydroxy- (7) Salicylic acid (CAS No. 69-72-7)
Regulatory evidence in all 13 markets
Open each matched record for its scope, concentration, conditions, warnings and official source version.
Swipe or scroll horizontally to see dataset coverage and next actions.
| Market | Result | Records | Dataset | Meaning / next action |
|---|---|---|---|---|
| European Union EU | Restricted | 1Open record 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | Review every linked record and exact conditions. |
| Great Britain GB | Restricted | 2Open record 1Open record 2 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | Review every linked record and exact conditions. |
| Canada CA | Restricted | 1Open record 1 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | Review every linked record and exact conditions. |
| New Zealand NZ | Restricted | 2Open record 1Open record 2 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Review every linked record and exact conditions. |
| ASEAN ASEAN | Restricted | 2Open record 1Open record 2 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Review every linked record and exact conditions. |
| China CN | No local match | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | Restricted | 1Open record 1 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | Review every linked record and exact conditions. |
| South Korea KR | Restricted | 2Open record 1Open record 2 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Review every linked record and exact conditions. |
| United States US | No local match | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | No local match | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | No local match | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Restricted | 1Open record 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | Review every linked record and exact conditions. |
| Saudi Arabia SA | Restricted | 1Open record 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Review every linked record and exact conditions. |
No market rows match this filter.
Matching market records and conditions
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026Salicylic acidPermitted list with conditions
0,5% (acid) · Not to be used in products for children under 3 years of age. · Not to be used for children under 3 years of age
GB Cosmetics Regulation, Annex V, entry 3 · 2026-08-15
Salicylic acidRestricted
Rinse-off hair products
Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant
Body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant · 3,0%
2,0%
0.5% · Not to be used in preparations for children under 3 years of age.
Not …
GB Cosmetics Regulation, Annex III, entry 98 · 2026-08-15
Canada
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026Salicylic acid and its saltsPermitted list with conditions
Maximum concentration: 0.5% (acid) · Other limitations: For salicylic acid: Not to be used in preparations for children under three years of age Not to be used in oral products Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation For sal…
Schedule 7, reference 3, source row 22 · effective-2026-01-01
Salicylic acid (benzoic acid, 2-hydroxy-)Restricted
Product scope: (a) Rinse-off hair products (b) Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant (c) Body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant · Maximum concentration: (a) 3.0% (b) 2.0% (c) 0.5% · Other li…
Schedule 5, reference 98, source row 127 · effective-2026-01-01
ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026Salicylic acid (69-72-7) and its salts(1) : Calcium salicylate (CAS No. 824-35- 1), Magnesium salicylate (CAS No. 18917-89- 0), MEA-salicylate (CAS No. 59866-70-5), Sodium salicylate (CAS No. 54-21-7), Potassium salicylate (CAS No. 578-36-9), TEA- salicylate (CAS No. 2174-16-5)Permitted list with conditions
0.5% (acid) 0.5% (acid) · Salicylic acid: Not to be used in products for children under three years of age. Not to be used in oral products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Salicylic acid salts: Not to be used in pr…
ASEAN Annex VI, reference 3 · 2026-1
Benzoic acid, 2-hydroxy- Salicylic acid CAS No 69-72-7Restricted
(a) Rinse-off hair products (b) Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant, nail polish (c) Body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant, nail polish · (a) 3.0 % (b) 2.0% (c) 0.5% · (a) (b) (c) Not to …
ASEAN Annex III, reference 98 · 2026-1
Japan
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshotSouth Korea
MFDS Notice 2026-19, effective 18 March 2026살리실릭애씨드 및그 염류Restricted
살리실릭애씨드 로서 0.5% · 영유아용 제품류 또는 만 13세 이하 어린이가 사용할 수 있음을 특정하여 표시하는 제품에는 사용금지(다만, 샴푸는 제외) · 살리실릭애씨드칼슘살리실레이트마그네슘살리실레이트
화장품 안전기준 등에 관한 규정, 별표 2, record 2-50 · 2026-19
살리실릭애씨드 및 그염류Restricted
?인체세정용 제품류에 살리실릭애 씨드로서 2% ?사용 후 씻어내는 두발용 제품류에 살리실릭애 씨드로서 3% · ?영유아용 제품류 또는 만 13세 이하 어린이가 사용할 수 있음을 특정하여 표시하는 제품에는 사용금지 (다만, 샴푸는 제외) ?기능성화 장품의 유효성분 으로 사용하는 경우에 한하며 기타 제품에는 사용금지 · 살리실릭애씨드칼슘살리실레이트마그네슘살리실레이트엠이에이-살리실레이트소듐살리실레이트포타슘살리실레이트티이에이-살리실레이트베타인살리실레이트
화장품 안전기준 등에 관한 규정, 별표 2, record 2-318 · 2026-19
India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Exact Annex II–VI evidence
Annex IIIentry 98
Open full regulatory recordSALICYLIC ACID
Product scope: (a) Rinse-off hair products (b) Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant (c) Body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant
Maximum concentration: (a) 3.0% (b) 2.0% (c) 0.5%
Restrictions: (a) (b) (c) Not to be used in preparations for children under 3 years of age. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products. For purposes other than inhibiting the development of micro-organisms in the product. This purpose has to be apparent from the presentation of the product. These levels are inclusive of any use of salicylic acid.
Warnings: (a) (b) (c) Not to be used for children under 3 years of age* * Solely for products which might be used for children under 3 years of age.
Chemical identity and properties
CAS 17671-53-3PubChem CID 71587021
Betaine salicylate
- IUPAC name
- carboxymethyl(trimethyl)azanium;2-carboxyphenolate
- Molecular formula
- C12H17NO5
- Molecular weight
- 255.27 g/mol
- Exact mass
- 255.11067264 Da
- Topological polar surface area
- 97.7 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 5
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
Betaine, salicylate(Carboxymethyl)trimethylammonium salicylateUNII-DRF395F9AYDRF395F9AYMethanaminium, 1-carboxy-N,N,N-trimethyl-, 2-hydroxybenzoate (1:1)Benzoic acid, 2-hydroxy-, ion(1-), 1-carboxy-N,N,N-trimethylmethanaminiumMethanaminium, 1-carboxy-N,N,N-trimethyl-, salt with 2-hydroxybenzoic acid (1:1)RefChem:119536
4 more reported names
BETAINE SALICYLATE [INCI](carboxymethyl)trimethylazanium 2-carboxybenzen-1-olate1-Carboxy-N,N,N-trimethylmethanaminium 2-hydroxybenzoateCarboxy-N,N,N-trimethylmethanaminium 2-carboxyphenolate
External database identifiers
- EPA DTXSID:DTXSID60170177
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 18917-89-0PubChem CID 54684589
(T-4)-Bis(2-(hydroxy-kappaO)benzoato-kappaO)magnesium
- IUPAC name
- magnesium bis(2-carboxyphenolate)
- Molecular formula
- C14H10MgO6
- Molecular weight
- 298.53 g/mol
- Exact mass
- 298.0327797 Da
- Topological polar surface area
- 121.0 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 6
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
Magnesium salicylateMagnesium salicylate anhydrousMagnesium disalicylateBackache reliefJQ69D454N1Backache CapletsBayer Select BackacheBackprin
16 more reported names
DoansBack Pain ReliefDoans Extra StrengthDoans Maximum StrengthMedique Back Pain ReliefRefChem:408391Unishield Back Pain ReliefMaximum Strength Backache ReliefMedique at Home Back Pain ReliefBack Pain Relief Extra Strength Doans242-669-3Magnesium Salicylate TetrahydrateMaganmagnesiumsalicylateMobidinmagnesium;2-carboxyphenolate
External database identifiers
- ChEMBL:CHEMBL2106755
- EPA DTXSID:DTXSID00889392
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 2174-16-5PubChem CID 25213
Trolamine Salicylate
- IUPAC name
- 2-[bis(2-hydroxyethyl)amino]ethanol;2-hydroxybenzoic acid
- Molecular formula
- C13H21NO6
- Molecular weight
- 287.31 g/mol
- Exact mass
- 287.13688739 Da
- Topological polar surface area
- 121.0 Ų
- Hydrogen-bond donors
- 5
- Hydrogen-bond acceptors
- 7
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
Triethanolamine salicylateTEA-SalicylateTEA salicylateNeo heliopan tsNeotan wArthricreamH8O4040BHDTrolamine salicylate (USP)
16 more reported names
Trolamine salicylate [USP]CannaflexHempvanaArthritis CreamArthritis LeaderArthritis ReliefAsper-FlexAsper-Flex CreamTrolamin SalicylateArthritis with AloeHempvana Pain ReliefArthricream with AloeDCH Arthritis ReliefXCEPTOL PAINCopperlife Pain ReliefCBD Pain Relief Cream
External database identifiers
- ChEMBL:CHEMBL2107288
- EPA DTXSID:DTXSID4047969
- PubMed:24312851
- PubMed:19078236
- PubMed:18796932
- PubMed:8876850
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 54-21-7PubChem CID 16760658
Sodium Salicylate
Sodium salicylate is an organic molecular entity. — ChEBI
- IUPAC name
- sodium 2-hydroxybenzoate
- Molecular formula
- C7H5NaO3
- Molecular weight
- 160.10 g/mol
- Exact mass
- 160.01363830 Da
- Topological polar surface area
- 60.4 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 3
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
EnterosalicylKerasalicylAlysineBenzoic acid, 2-hydroxy-, monosodium saltNatrum salicylicumSalicylic acid sodium saltsalicylate sodiumMonosodium 2-hydroxybenzoate
16 more reported names
Natrii salicylasWIQ1H85SYPSalicylate, sodiumNSC-202167Benzoic acid, 2-hydroxy-, sodium salt (1:1)Sod salPro-PrinSaliGard 60RefChem:6246UNI-SOLUNI-SOL 60Aspen Sodium Salicylate 48.6%AquaPrime Liquid Sodium SalicylateAquasource Aqua-Prin Water Soluble Sodium Salicylate200-198-0Salsonin
External database identifiers
- ChEBI:CHEBI:9180
- ChEMBL:CHEMBL447868
- EPA DTXSID:DTXSID5021708
- PubMed:29117515
- PubMed:23652544
- PubMed:23504962
- PubMed:22898132
- PubMed:21303813
- PubMed:19767084
- PubMed:19173110
- PubMed:19026709
- PubMed:18560754
- PubMed:18483001
- PubMed:17568627
- PubMed:17561093
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 578-36-9PubChem CID 23664627
Potassium Salicylate
- IUPAC name
- potassium 2-hydroxybenzoate
- Molecular formula
- C7H5KO3
- Molecular weight
- 176.21 g/mol
- Exact mass
- 175.98757550 Da
- Topological polar surface area
- 60.4 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 3
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
Salicylic acid potassium saltK91YT16P5MUNII-K91YT16P5MBenzoic acid, 2-hydroxy-, monopotassium saltPOTASSIUM SALICYLATE [MI]EINECS 209-421-6Benzoic acid, 2-hydroxy-, potassium salt (1:1)POTASSIUM SALICYLATE [VANDF]
11 more reported names
POTASSIUM SALICYLATE [WHO-DD]RefChem:175593POTASSIUM SALICYLATE [INCI]209-421-6potassium,2-hydroxybenzoatepotassium;2-hydroxybenzoateSALICYLIC ACID (POTASSIUM)PotassiumsalicylateAS-15221FT-0632428EN300-20085
External database identifiers
- ChEMBL:CHEMBL3707342
- EPA DTXSID:DTXSID9060366
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 59866-70-5PubChem CID 3085170
Salicylic acid monoethanolamine
- IUPAC name
- 2-aminoethanol;2-hydroxybenzoic acid
- Molecular formula
- C9H13NO4
- Molecular weight
- 199.20 g/mol
- Exact mass
- 199.08445790 Da
- Topological polar surface area
- 104.0 Ų
- Hydrogen-bond donors
- 4
- Hydrogen-bond acceptors
- 5
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
MEA-SALICYLATEUNII-078ORG4DXO078ORG4DXOEINECS 261-963-2Salicylic acid, compound with 2-aminoethanol (1:1)Monoethanolamine SalicylateSALICYLIC ACID ETHANOLAMINE SALTSALICYLIC ACID, 2-AMINOETHANOL SALT
7 more reported names
SALICYLIC ACID MONOETHANOLAMINE [WHO-DD]ETHANOL, 2-AMINO-, 2-HYDROXYBENZOATE (SALT)RefChem:180924MEA-SALICYLATE [INCI]Ethanolamine salicylate [WHO-DD]WGPVWXXJNUNBNB-UHFFFAOYSA-N2-Hydroxybenzoic acid--2-aminoethan-1-ol (1/1)
External database identifiers
- EPA DTXSID:DTXSID80208587
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 69-72-7PubChem CID 338
Salicylic Acid
Salicylic acid is a monohydroxybenzoic acid that is benzoic acid with a hydroxy group at the ortho position. It is obtained from the bark of the white willow and wintergreen leaves. It has a role as an antiinfective agent, an antifungal agent, a plant hormone, a keratolytic drug, an EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor, a plant metabolite and an algal metabolite. It is a conjugate acid of a salicylate. — ChEBI
- IUPAC name
- 2-hydroxybenzoic acid
- Molecular formula
- C7H6O3
- Molecular weight
- 138.12 g/mol
- Exact mass
- 138.031694049 Da
- XLogP3
- 2.3
- Topological polar surface area
- 57.5 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 3
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
o-hydroxybenzoic acid2-Carboxyphenolo-CarboxyphenolRetarder WRutranexSalonilKeralytDuoplant
16 more reported names
FreezoneSaligelIonilPsoriacid-S-stiftBenzoic acid, 2-hydroxy-Stri-DexSalicylic acid soapVerrugonSalicylic acid collodionPhenol-2-carboxylic acid2-Hydroxybenzenecarboxylic acidTrans-Ver-SalOrthohydroxybenzoic acidAcidum salicylicumAcido salicilicoIonil-Plus
External database identifiers
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 824-35-1PubChem CID 54684600
Calcium Salicylate
- IUPAC name
- calcium bis(2-carboxyphenolate)
- Molecular formula
- C14H10CaO6
- Molecular weight
- 314.30 g/mol
- Exact mass
- 314.0103289 Da
- Topological polar surface area
- 121.0 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 6
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
Calcium disalicylateBenzoic acid, 2-hydroxy-, calcium salt (2:1)0841QCS0DKRefChem:573557212-525-4Calcium 2-hydroxybenzoateUNII-0841QCS0DKEINECS 212-525-4
5 more reported names
CALCIUMSALICYLATEcalcium bis(2-hydroxybenzoate)CALCIUM SALICYLATE [II]CALCIUM SALICYLATE [WHO-DD]DB-056609
External database identifiers
- EPA DTXSID:DTXSID60890489
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Additional authoritative substance research
These source-specific lookups can add hazard, toxicology, identity and assessment context. A link is a research route, not a claim that the source contains an exact record.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Research this identityFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Research this identityILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Research this identityJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Research this identityNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Research this identityOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Research this identityUS EPA CompTox CTX APIs
DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Research this identityContinue the compliance check
1. Confirm identity
Match the supplier specification, CAS/EC identifiers and composition to this official label name. Similar wording is not proof of chemical equivalence.
2. Review restrictions
Check every exact Annex record shown above, plus CMR, nanomaterial, SCCS and later-amendment requirements that may apply.
3. Verify the formula
Evaluate concentration, product type, purity, warnings, claims and each target market before making a compliance decision.
Official source and scope
Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.
Open official Decision